Gaelle Muller-Greven
Affiliations: | Cancer Biology | Cleveland Clinic Lerner College of Medicine, Cleveland, OH, United States |
Google:
"Gaelle Muller-Greven"Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hashemi-Sadraei N, Müller-Greven GM, Abdul-Karim FW, et al. (2018) Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer. Journal of Neuro-Oncology |
| Muller-Greven G, Marin B, Carlin C, et al. (2018) CADD-57. THE EFFICACY OF THERAPY WITH ABT-414, AN EGFR-TARGETING ADC, IS POTENTIALLY ALTERED BY HETEROZYGOUS DELETION OF THE ENDOCYTIC TRAFFICKING REGULATOR RBSN Neuro-Oncology. 20: vi283-vi284 |
| Müller-Greven GM, Carlin C, Burgett ME, et al. (2017) Macropinocytosis of Bevacizumab by Glioblastoma Cells in the Perivascular Niche Affects their Survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Muller-Greven G, Carlin C, Toms S, et al. (2016) Abstract 3276: The tissue and cellular destination of therapeutic IgGs in glioblastoma Cancer Research. 76: 3276-3276 |
| Muller-Greven G, Carlin C, Toms S, et al. (2016) STMC-30. TRAFFICKING AND EFFECT ON SURVIVAL OF BEVACIZUMAB IN GLIOBLASTOMA Neuro-Oncology. 18: vi188-vi189 |
| Muller-Greven G, Carlin C, Lathia J, et al. (2015) Abstract 5226: Glioma stem cells internalize perivascular bevacizumab via a non-canonical pathway and target it for recycling or degradation Cancer Research. 75: 5226-5226 |
| Muller-Greven G, Carlin C, Toms S, et al. (2015) STEM-12FATE OF BEVACIZUMAB IN GLIOBLASTOMA Neuro-Oncology. 17: v210.4-v210 |
| Muller-Greven G, Carlin C, Lathia J, et al. (2014) SC-22 * GLIOMA STEM CELLS INTERNALIZE BEVACIZUMAB FOUND IN THE PERIVASCULAR NICHE AND TARGET IT FOR RECYCLING OR DEGRADATION Neuro-Oncology. 16: v201-v201 |
| Bae E, Smith L, Muller-Greven G, et al. (2014) AI-03 * TARGETING ANGIOGENESIS WITHOUT INCREASING THE STROMAL CELL RESPONSE OR INVASION USING ABT-898, A THROMBOSPONDIN TYPE 1 REPEAT PEPTIDE Neuro-Oncology. 16: v1-v1 |
| Liu WM, Huang P, Kar N, et al. (2013) Lyn facilitates glioblastoma cell survival under conditions of nutrient deprivation by promoting autophagy. Plos One. 8: e70804 |